1. Home
  2. LGND vs GEF Comparison

LGND vs GEF Comparison

Compare LGND & GEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • GEF
  • Stock Information
  • Founded
  • LGND 1987
  • GEF 1877
  • Country
  • LGND United States
  • GEF United States
  • Employees
  • LGND 68
  • GEF N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • GEF
  • Sector
  • LGND Health Care
  • GEF
  • Exchange
  • LGND Nasdaq
  • GEF Nasdaq
  • Market Cap
  • LGND 3.2B
  • GEF 3.5B
  • IPO Year
  • LGND 1992
  • GEF N/A
  • Fundamental
  • Price
  • LGND $184.49
  • GEF $60.13
  • Analyst Decision
  • LGND Strong Buy
  • GEF Hold
  • Analyst Count
  • LGND 8
  • GEF 4
  • Target Price
  • LGND $144.71
  • GEF $71.50
  • AVG Volume (30 Days)
  • LGND 139.7K
  • GEF 179.2K
  • Earning Date
  • LGND 08-05-2025
  • GEF 11-05-2025
  • Dividend Yield
  • LGND N/A
  • GEF 3.69%
  • EPS Growth
  • LGND N/A
  • GEF N/A
  • EPS
  • LGND N/A
  • GEF 4.00
  • Revenue
  • LGND $181,488,000.00
  • GEF $5,432,000,000.00
  • Revenue This Year
  • LGND $18.41
  • GEF N/A
  • Revenue Next Year
  • LGND $18.87
  • GEF N/A
  • P/E Ratio
  • LGND N/A
  • GEF $15.18
  • Revenue Growth
  • LGND 53.40
  • GEF 19.22
  • 52 Week Low
  • LGND $81.74
  • GEF $48.23
  • 52 Week High
  • LGND $129.90
  • GEF $73.16
  • Technical
  • Relative Strength Index (RSI)
  • LGND 79.42
  • GEF N/A
  • Support Level
  • LGND $179.40
  • GEF N/A
  • Resistance Level
  • LGND $184.26
  • GEF N/A
  • Average True Range (ATR)
  • LGND 4.60
  • GEF 0.00
  • MACD
  • LGND 0.44
  • GEF 0.00
  • Stochastic Oscillator
  • LGND 100.00
  • GEF 0.00

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

Share on Social Networks: